
Linda Armstrong, Global Head, Respiratory Development Unit at Novartis.

Ann Costello, Global Franchise Lead, Centralised Solutions at Roche Diagnostics, discusses the increasing need for a personalised approach to patient …

Vaila Morrison’s daughter Eilidh was born with the ultra-rare condition KAT6A. As a designer and architect by profession, Vaila told …

Patient-reported outcomes measures are an invaluable tool in ensuring that the patient remains in the driving seat when it comes …

Dr Thomas Endress, Founder, and Dr Frederic Berkermann, co-?Founder, of a new technology being developed at the Merck Innovation Center …

With debates heating up over cooperation between European across the continent, Matt Fellows investigates the current state of packaging countermeasures …

Ipsen’s Vice President of HR Speciality Care discusses the path she has taken throughout her career, the cultural differences she …

Dr Bill Love, Founder and Chief Scientific Officer of Destiny Pharma, discusses the rise of antimicrobial resistance (AMR), the antibiotic …

Could you give a short history of how you came to be in your current role? I’ve spent my entire …

Joaquin Casariego Garcia Luben, Medical Affairs Director Europe, Middle East & Africa, Prostate Cancer for Johnson & Johnson (pictured) discusses …

The NHS is sick. According to politicians and NHS chiefs, the cure involves a strong dose of mHealth. Louis Goss …

The impasse over access to Vertex’s Orkambi for cystic fibrosis patients in England and Wales has revealed the cracks in …

Novo Nordisk’s VP and CMO discusses his leap from family medicine into the pharma industry, his biggest achievements, and how …

Spinnaker Opportunities announced in February it had reached a preliminary agreement to acquire cannabis oil-focused research firm Kanabo Research and …

Rebecca Pender’s daughter Hannah lives with the ultra-rare condition Inv Dup Del 8p, a genetic arrangement that affects just 80 …